Daniel Gottlieb

Daniel serves as a Director of the MedTech portfolio at Broadview Ventures and is a board member of several companies including Cardiosense, XII Medical, CroiValve, and Nyra Medical (observer). Previously, Daniel was Vice President, Corporate Development, at Proteon Therapeutics. Prior to Proteon, Daniel held operational roles at Abbott Vascular and Guidant, and was a member of Guidant Compass, the company’s corporate venture capital, business development, and corporate strategy group. Daniel holds a BA from the University of Pennsylvania and an MBA from the Tuck School of Business at Dartmouth College.